Compare BANF & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BANF | ITGR |
|---|---|---|
| Founded | 1984 | 1970 |
| Country | United States | United States |
| Employees | 2260 | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.3B |
| IPO Year | 1994 | 2000 |
| Metric | BANF | ITGR |
|---|---|---|
| Price | $115.80 | $125.26 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $124.00 | $91.14 |
| AVG Volume (30 Days) | 116.7K | ★ 1.5M |
| Earning Date | 04-16-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.76% | N/A |
| EPS Growth | ★ 10.40 | N/A |
| EPS | ★ 3.81 | 1.17 |
| Revenue | N/A | ★ $1,853,637,000.00 |
| Revenue This Year | $6.10 | $1.69 |
| Revenue Next Year | $3.92 | $6.53 |
| P/E Ratio | ★ $30.36 | $106.89 |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $101.48 | $62.00 |
| 52 Week High | $138.15 | $126.14 |
| Indicator | BANF | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 55.75 | 82.68 |
| Support Level | $110.55 | $82.58 |
| Resistance Level | $115.73 | $126.14 |
| Average True Range (ATR) | 1.98 | 2.71 |
| MACD | 0.09 | 0.67 |
| Stochastic Oscillator | 59.08 | 97.01 |
BancFirst Corp is engaged in providing banking services. The company's business unit includes BancFirst metropolitan banks, BancFirst community banks, Pegasus Bank, Worthington, other financial services and executive, operations and support. BancFirst metropolitan banks, BancFirst community banks, Pegasus and Worthington offer traditional banking products such as commercial and retail lending and a full line of deposit accounts. Its Other financial services are specialty product business units including guaranteed small business lending, residential mortgage lending, trust services, securities brokerage, electronic banking, and insurance.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.